Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive intravenous ketorolac versus paracetamol for postoperative pain after septorhinoplasty
IRCT20180922041084N6Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketorolac and acetaminophen in postoperative pain (3 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Postoperative pain. Started Apr 2022; status: completed.
02
Drugs
ketorolacacetaminophen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20180922041084N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180922041084N6.